However, while this work focused on the imbalance of cardiac phosphorylation by overexpression of PP2A as a hypertrophy model, it should be kept in mind that cardiac hypertrophy and/or dysfunction can be experimentally achieved by various methods, including, for example, ablation of 5-HT2B receptors [72,73]. This evidence concerns the gene PTPA and cardiac hypertrophy.